Metabolic Syndrome: A Registry Study of Patients in the Russian Federation (METEOR). Rationale, objectives, design, and methodology
Open Access
- 23 September 2026
- journal article
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (10S) , 7128
Abstract
This paper presents the rationale, design, and methodology of the prospective, observational, multicenter study "Metabolic Syndrome: A Registry Study of Patients in the Russian Federation (METEOR)". The are following study aims: to describe the clinical and demographic characteristics, diagnostic methods, and treatment options used in outpatients with metabolic syndrome (MS) in a real-world clinical practice; to evaluate baseline characteristics and progression across MS stages within various phenotypes; and to identify factors associated with clinical outcomes during the follow-up period in the general patient population and in subgroups of interest. The study will sequentially enroll all adult outpatients with MS who are followed up by a general practitioner, primary care physician, and/or specialized professionals, who have signed an informed consent, and who meet the inclusion criteria. Data will be collected on a single digital platform in the patient’s electronic individual case report form. The follow-up period begins on the day of Visit 1, with Visit 2 occurring 6 months (±3 months) after Visit 1. Visit 3 and subsequent visits will be conducted 12 months (±3 months) after Visit 1, and then annually thereafter collect information on the patient’s clinical status and endpoints.Keywords
This publication has 17 references indexed in Scilit:
- Interim analysis of prospective observational multicenter study of patients with hypertension and chronic kidney disease in the Russian Federation (PRIORITY-CKD)Russian Journal of Cardiology, 2025
- Concept of an interdisciplinary consensus document on cardiovascular-renal-hepatic-metabolic syndromeRussian Journal of Cardiology, 2025
- The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050JACC, 2025
- Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021The Lancet, 2025
- Sex Differences in Cardiovascular-Kidney-Metabolic Syndrome: 30-Year US Trends and Mortality Risks—Brief ReportArteriosclerosis, Thrombosis, and Vascular Biology, 2025
- Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 studyCardiovascular Therapy and Prevention, 2023
- Obesity in the Russian population during the COVID-19 pandemic and associated factors. Data from the ESSE-RF3 studyCardiovascular Therapy and Prevention, 2023
- Dyslipidemia in the Russian Federation: population data, associations with risk factorsCardiovascular Therapy and Prevention, 2023
- Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the Federal diabetes register data of 01.01.2021Diabetes mellitus, 2021
- Metabolic syndrome and its associations with socio-demographic and behavioral risk factors in the Russian population aged 25-64 yearsCardiovascular Therapy and Prevention, 2020